Epithelial Cell Adhesion Molecule in Primary Sjögren’s Syndrome Patients: Characterization and Evaluation of a Potential Biomarker

Table 2

Risk factor analysis for pSS patients.

	pSS patients			pSS patients at early stage
Factors	OR	value	95% CI	OR	value	95% CI
Membranous EpEX	10.587	0.009	1.797-62.382	6.115	0.033	1.154-32.414
Membranous EpICD	61.972	0.058	0.870-4416.473	0.139	0.287	0.004-5.260
Cytoplasmic EpICD	0.019	0.093	0.000-1.944	5.815	0.272	0.252-134.223
Nuclear EpICD	3.659	0.301	0.313-42.743
Female	0.408	0.520	0.027-6.244	1.371	0.793	0.130-14.463
Xerostomia	0.469	0.589	0.030-7.335
Saprodontia	5.354	0.171	0.485-59.043	9.028	0.058	0.928-87.849
Anti-SSA	0.784	0.684	0.277-0.222	0.761	0.522	0.330-1.754
ANA	0.437	0.337	0.022-5.236
ANA and RF	1.304	0.837	0.104-16.394
Anti-Ro52	1.195	0.867	0.150-9.531